• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mirati Therapeutics Inc

+ Add to Watchlist

MRTX:US

18.8100 USD 0.2700 1.46%

As of 20:10:00 ET on 08/22/2014.

Snapshot for Mirati Therapeutics Inc (MRTX)

Open: 19.0700 Day's Range: 18.5000 - 19.0700 Volume: 48,616
Previous Close: 18.5400 52wk Range: 8.1200 - 25.9699 1-Yr Rtn: +122.87%

Stock Chart for MRTX

No chart data available.
  • MRTX:US 18.8100
  • 1D
  • 1M
  • 1Y
18.5400
Interactive MRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -5.7887
Est. EPS (CAD) (12/2014) -3.9130
Est. PEG Ratio -
Market Cap (M USD) 254.59
Shares Outstanding (M) 13.53
30 Day Average Volume 29,969
Price/Book (mrq) 20.4078
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRTX

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for MRTX

Mirati Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.

Mark J GergenExec VP/COO/SecretaryCharles M BaumPresident/CEO
Isan ChenExec VP/Chief Medical OfcrJames ChristensenSenior VP/Chief Scientfic Ofcr
More Company Profile & Key Executives for MRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil